JP7897689B2 - エキソソーム細胞外小胞及びその使用方法 - Google Patents
エキソソーム細胞外小胞及びその使用方法Info
- Publication number
- JP7897689B2 JP7897689B2 JP2020573481A JP2020573481A JP7897689B2 JP 7897689 B2 JP7897689 B2 JP 7897689B2 JP 2020573481 A JP2020573481 A JP 2020573481A JP 2020573481 A JP2020573481 A JP 2020573481A JP 7897689 B2 JP7897689 B2 JP 7897689B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- lnp
- mrna
- hepo
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024034020A JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862691348P | 2018-06-28 | 2018-06-28 | |
| US62/691,348 | 2018-06-28 | ||
| PCT/EP2019/067232 WO2020002540A1 (en) | 2018-06-28 | 2019-06-27 | Exosome extracellular vesicles and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024034020A Division JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021528096A JP2021528096A (ja) | 2021-10-21 |
| JP2021528096A5 JP2021528096A5 (cg-RX-API-DMAC7.html) | 2022-07-04 |
| JP7897689B2 true JP7897689B2 (ja) | 2026-07-30 |
Family
ID=67139730
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573481A Active JP7897689B2 (ja) | 2018-06-28 | 2019-06-27 | エキソソーム細胞外小胞及びその使用方法 |
| JP2024034020A Withdrawn JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024034020A Withdrawn JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12109310B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3813798A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7897689B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112543629A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020002540A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| TW202220637A (zh) * | 2020-08-06 | 2022-06-01 | 美商現代公司 | 製備脂質奈米顆粒之方法 |
| JP7633787B2 (ja) * | 2020-09-23 | 2025-02-20 | 三洋化成工業株式会社 | 細胞外小胞の製造方法 |
| MX2023004371A (es) | 2020-10-14 | 2023-07-26 | George Mason Res Foundation Inc | Lípidos ionizables, y métodos de fabricación y uso de los mismos. |
| EP4387657A4 (en) * | 2021-08-17 | 2025-05-21 | Monash University | Lipid nanoparticle formulations |
| WO2023178500A1 (en) * | 2022-03-22 | 2023-09-28 | Beijing Theraxyte Bioscience Co. Ltd. | Therapeutic vesicles and methods of processing the same |
| CN114848608B (zh) * | 2022-05-17 | 2024-01-30 | 东南大学 | 一种蛋白或多肽递送载体及其制备方法与应用 |
| CN115887758B (zh) * | 2022-11-15 | 2024-01-26 | 西南交通大学 | 负载外泌体促进糖尿病创面修复的共聚水凝胶 |
| CN117679354B (zh) * | 2024-02-04 | 2024-05-28 | 知想(山东)医疗科技有限公司 | 金花茶外泌体制剂及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010285426A (ja) | 2009-05-11 | 2010-12-24 | National Cancer Center | 核酸導入方法 |
| JP2012524052A (ja) | 2009-04-17 | 2012-10-11 | アイシス イノヴェイション リミテッド | 遺伝物質の送達用の組成物 |
| JP2015501844A (ja) | 2011-12-16 | 2015-01-19 | モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. | 修飾ヌクレオシド、ヌクレオチドおよび核酸組成物 |
| JP2017502997A (ja) | 2014-01-21 | 2017-01-26 | アンヤリウム バイオサイエンシーズ アーゲー | ハイブリドソーム、それを含む組成物、それらの製造方法、およびその使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| CN103068980B (zh) | 2010-08-02 | 2017-04-05 | 瑟纳治疗公司 | 使用短干扰核酸(siNA)的RNA干扰介导的联蛋白(钙粘蛋白关联蛋白质),β1(CTNNB1)基因表达的抑制 |
| US8691750B2 (en) | 2011-05-17 | 2014-04-08 | Axolabs Gmbh | Lipids and compositions for intracellular delivery of biologically active compounds |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| EP3247328B1 (en) * | 2015-01-21 | 2026-01-07 | Genevant Sciences Gmbh | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
| EP3500244B1 (en) * | 2016-08-22 | 2026-07-08 | Lonza Sales AG | Methods of suppressing delivery of exosomes to liver and spleen |
| EP3292861A1 (en) | 2016-09-13 | 2018-03-14 | Centre National De La Recherche Scientifique (Cnrs) | An in vitro method for obtaining a biohybrid vector |
-
2019
- 2019-06-27 CN CN201980042830.1A patent/CN112543629A/zh active Pending
- 2019-06-27 EP EP19735277.6A patent/EP3813798A1/en active Pending
- 2019-06-27 US US16/972,190 patent/US12109310B2/en active Active
- 2019-06-27 JP JP2020573481A patent/JP7897689B2/ja active Active
- 2019-06-27 WO PCT/EP2019/067232 patent/WO2020002540A1/en not_active Ceased
-
2024
- 2024-03-06 JP JP2024034020A patent/JP2024081661A/ja not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012524052A (ja) | 2009-04-17 | 2012-10-11 | アイシス イノヴェイション リミテッド | 遺伝物質の送達用の組成物 |
| JP2010285426A (ja) | 2009-05-11 | 2010-12-24 | National Cancer Center | 核酸導入方法 |
| JP2015501844A (ja) | 2011-12-16 | 2015-01-19 | モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. | 修飾ヌクレオシド、ヌクレオチドおよび核酸組成物 |
| JP2017502997A (ja) | 2014-01-21 | 2017-01-26 | アンヤリウム バイオサイエンシーズ アーゲー | ハイブリドソーム、それを含む組成物、それらの製造方法、およびその使用 |
Non-Patent Citations (3)
| Title |
|---|
| NATURE COMMUNICATIONS, 2017年, 8: 1145, DOI:10.1038/s41467-017-01196-x, p. 1-15 |
| THE NEW ENGLAND JOURNAL OF MEDICINE, 1996年, Vol.334 No.17, pp.1135-1138 |
| 膜(MEMBRANE),2015年, 40(5),p.235-241 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20210315819A1 (en) | 2021-10-14 |
| CN112543629A (zh) | 2021-03-23 |
| JP2024081661A (ja) | 2024-06-18 |
| WO2020002540A1 (en) | 2020-01-02 |
| EP3813798A1 (en) | 2021-05-05 |
| US12109310B2 (en) | 2024-10-08 |
| JP2021528096A (ja) | 2021-10-21 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220624 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220624 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230530 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230606 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230905 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231107 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240306 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20240423 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20240502 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20240614 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20250217 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260717 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7897689 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |